NCT06398093 Developing and Testing a Self-Compassion Tool Kit to Improve the Care of Individuals With Type 2 Diabetes
| NCT ID | NCT06398093 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of California, San Diego |
| Condition | Type 2 Diabetes |
| Study Type | INTERVENTIONAL |
| Enrollment | 30 participants |
| Start Date | 2024-07-15 |
| Primary Completion | 2024-08 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 30 participants in total. It began in 2024-07-15 with a primary completion date of 2024-08.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
There is a high prevalence of anxiety and depression in patients with Type 2 Diabetes (T2D). While past studies demonstrate the potential therapeutic effect of mindfulness-based interventions in patients with T2D, little is understood about the mode of delivery or quantity of the intervention necessary to experience benefits. This project aims to develop and implement a self-compassion tool kit based on the principles of mindfulness and meditation to better understand how self-compassion works to affect psychological health and wellbeing in patients with T2D. The investigators will study the impact of a self-compassion tool kit - including mindfulness meditation, exercise, journaling and sleep parameters - on T2D. Enhancing emotional well-being could complement current T2D treatments to facilitate improved quality of life.
Eligibility Criteria
Inclusion Criteria: * Has type 2 diabetes * Has a score above 2 on the T2D Distress Assessment Scale Exclusion Criteria: * Does not have type 2 diabetes * Has a score above 2 on the T2D Distress Assessment Scale * Cannot safely exercise * Cannot complete the requested tasks
Contact & Investigator
Edward C Chao, DO
PRINCIPAL INVESTIGATOR
UCSD
Frequently Asked Questions
Who can join the NCT06398093 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Type 2 Diabetes. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06398093 currently recruiting?
Yes, NCT06398093 is actively recruiting participants. Contact the research team at aaxinn@health.ucsd.edu for enrollment information.
Where is the NCT06398093 trial being conducted?
This trial is being conducted at San Diego, United States.
Who is sponsoring the NCT06398093 clinical trial?
NCT06398093 is sponsored by University of California, San Diego. The principal investigator is Edward C Chao, DO at UCSD. The trial plans to enroll 30 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.